BCL2 and Miyoshi myopathy: Additionally, in vivo experiments showed that TUG1 knockdown inhibited MM xenograft tumor growth by upregulating miR-34a-5p and downregulating the expression of NOTCH1, Hes-1, Survivin, and Bcl-2.